The United States Department of Justice (“DOJ”) is concerned that the dangers of Plavix® were not properly identified by its manufacturers Sanofi-Aventis and Bristol-Myers Squibb.  The DOJ is concerned that the manufacturers failed to disclose certain information in hopes of misleading consumers about the safety of the drug.  Studies show that certain individuals have a difficult time metabolizing Plavix®.  The DOJ was troubled with the warning and “is investigating disclosures to the FDA regarding the variability of response to Plavix” according to Sanofi. This is not the first time Sanofi and Bristol-Myers have been questioned about their Plavix® disclosures.  The FDA inquired into the drug’s safety back in 2003.   A warning was added to the box to flag the differences in Plavix®,effectiveness back in 2010.

If you feel you have experienced any side-effects from taking Plavix®, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the Plavix® manufacturers.